NC 758: Clinical Trials

1 trial of NC 758, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow NC 758: new trials by email Literature Review of NC 758 trials Research Report on NC 758

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy
NC-758 (Anti amyloidotic [Aß] agent) - Stroke, Neurologic Diseases, General
Phase 2CompletedBellus Health Inc. - a GSK company302003-02-012005-06-24

Conditions studied

Cerebral Amyloid Angiopathy (1)  ·  Hemorrhagic Stroke (1)  ·  Nervous System Diseases (1)  ·  Stroke (1)

Sponsors

Bellus Health Inc. - a GSK company (1)

Countries

United States (1)

Top investigators

Steven M. Greenberg, M.D., PhD. (1)